MSB 8.25% $1.05 mesoblast limited

Ann: Mesoblast Update on Chronic Low Back Pain Program, page-56

  1. 56 Posts.
    lightbulb Created with Sketch. 14
    A fairly unjustified statement there Gavsy.

    I am "another shareholder" and I see the good announcement as an opportunity to buy more rather than getting out.

    Investing in Biotechs will always be a rollercoaster ride and if people cannot enjoy the ride than they should stick to the theme parks!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.